These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20201827)

  • 1. Regulation of drug metabolism and transporters.
    Muntané J
    Curr Drug Metab; 2009 Oct; 10(8):932-45. PubMed ID: 20201827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems.
    Nakata K; Tanaka Y; Nakano T; Adachi T; Tanaka H; Kaminuma T; Ishikawa T
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):437-57. PubMed ID: 17220560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors.
    Xu D; Huang S; Wang H; Xie W
    Drug Metab Rev; 2018 Nov; 50(4):407-414. PubMed ID: 30501435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes.
    Kodama S; Koike C; Negishi M; Yamamoto Y
    Mol Cell Biol; 2004 Sep; 24(18):7931-40. PubMed ID: 15340055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of cholestasis.
    Zollner G; Trauner M
    Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites.
    Zamek-Gliszczynski MJ; Hoffmaster KA; Nezasa K; Tallman MN; Brouwer KL
    Eur J Pharm Sci; 2006 Apr; 27(5):447-86. PubMed ID: 16472997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate transcriptional regulation of transport and metabolism.
    Eloranta JJ; Meier PJ; Kullak-Ublick GA
    Methods Enzymol; 2005; 400():511-30. PubMed ID: 16399367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.
    Urquhart BL; Tirona RG; Kim RB
    J Clin Pharmacol; 2007 May; 47(5):566-78. PubMed ID: 17442683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes.
    Langmann T; Moehle C; Mauerer R; Scharl M; Liebisch G; Zahn A; Stremmel W; Schmitz G
    Gastroenterology; 2004 Jul; 127(1):26-40. PubMed ID: 15236169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of hepatic cytochromes p450 by lipids and cholesterol.
    Hafner M; Rezen T; Rozman D
    Curr Drug Metab; 2011 Feb; 12(2):173-85. PubMed ID: 21395540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
    Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
    Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes.
    Moscovitz JE; Kalgutkar AS; Nulick K; Johnson N; Lin Z; Goosen TC; Weng Y
    J Pharmacol Exp Ther; 2018 May; 365(2):262-271. PubMed ID: 29440451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.
    Wang H; LeCluyse EL
    Clin Pharmacokinet; 2003; 42(15):1331-57. PubMed ID: 14674787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics.
    Lamba J; Lamba V; Schuetz E
    Curr Drug Metab; 2005 Aug; 6(4):369-83. PubMed ID: 16101575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting drug metabolism induction in silico.
    Schuster D; Steindl TM; Langer T
    Curr Top Med Chem; 2006; 6(15):1627-40. PubMed ID: 16918474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.
    Yu AM; Tian Y; Tu MJ; Ho PY; Jilek JL
    Drug Metab Dispos; 2016 Mar; 44(3):308-19. PubMed ID: 26566807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes.
    Kandel BA; Thomas M; Winter S; Damm G; Seehofer D; Burk O; Schwab M; Zanger UM
    Biochim Biophys Acta; 2016 Sep; 1859(9):1218-1227. PubMed ID: 26994748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor.
    Köhle C; Bock KW
    Biochem Pharmacol; 2009 Feb; 77(4):689-99. PubMed ID: 18606396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.